<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" > <channel> <title>Corsair Pharma Archives - Slice of Healthcare</title> <atom:link href="https://sliceofhealthcare.com/tag/corsair-pharma/feed/" rel="self" type="application/rss+xml" /> <link>https://sliceofhealthcare.com/tag/corsair-pharma/</link> <description>Redefining Healthcare Media.</description> <lastBuildDate>Thu, 14 Dec 2023 01:15:02 +0000</lastBuildDate> <language>en-US</language> <sy:updatePeriod> hourly </sy:updatePeriod> <sy:updateFrequency> 1 </sy:updateFrequency> <generator>https://wordpress.org/?v=6.7.2</generator> <image> <url>https://i0.wp.com/sliceofhealthcare.com/wp-content/uploads/2023/05/cropped-Site-icon-slice-of-healthcare-2.png?fit=32%2C32&ssl=1</url> <title>Corsair Pharma Archives - Slice of Healthcare</title> <link>https://sliceofhealthcare.com/tag/corsair-pharma/</link> <width>32</width> <height>32</height> </image> <site xmlns="com-wordpress:feed-additions:1">190433015</site> <item> <title>Corsair Pharma Inc. Revolutionizes PAH Treatment with Appointment of George W. Mahaffey as CEO</title> <link>https://sliceofhealthcare.com/corsair-pharma-inc-revolutionizes-pah-treatment-with-appointment-of-george-w-mahaffey-as-ceo/</link> <dc:creator><![CDATA[Chris-Anne Roque]]></dc:creator> <pubDate>Wed, 13 Dec 2023 07:16:50 +0000</pubDate> <category><![CDATA[Hiring News]]></category> <category><![CDATA[News]]></category> <category><![CDATA[Corsair Pharma]]></category> <category><![CDATA[George W. Mahaffey]]></category> <category><![CDATA[Ivan Gergel]]></category> <category><![CDATA[New Rhein Healthcare]]></category> <category><![CDATA[United Therapeutics]]></category> <guid isPermaLink="false">https://sliceofhealthcare.com/?p=13669</guid> <description><![CDATA[<p>Key Highlights George W. Mahaffey appointed as CEO of Corsair Pharma, bringing over 35 years of experience in…</p> <p>The post <a href="https://sliceofhealthcare.com/corsair-pharma-inc-revolutionizes-pah-treatment-with-appointment-of-george-w-mahaffey-as-ceo/">Corsair Pharma Inc. Revolutionizes PAH Treatment with Appointment of George W. Mahaffey as CEO</a> appeared first on <a href="https://sliceofhealthcare.com">Slice of Healthcare</a>.</p> ]]></description> <content:encoded><![CDATA[ <div data-elementor-type="wp-post" data-elementor-id="13669" class="elementor elementor-13669" data-elementor-post-type="post"> <section class="elementor-section elementor-top-section elementor-element elementor-element-53265ad elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="53265ad" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b1fd0d8" data-id="b1fd0d8" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-219a45b elementor-widget elementor-widget-heading" data-id="219a45b" data-element_type="widget" data-widget_type="heading.default"> <div class="elementor-widget-container"> <h2 id="key-highlights" class="elementor-heading-title elementor-size-default">Key Highlights</h2> </div> </div> </div> </div> </div> </section> <section class="elementor-section elementor-top-section elementor-element elementor-element-ea205cb elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="ea205cb" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-37761df" data-id="37761df" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-6d09b4b elementor-widget elementor-widget-text-editor" data-id="6d09b4b" data-element_type="widget" data-widget_type="text-editor.default"> <div class="elementor-widget-container"> <ul><li><strong>George W. Mahaffey appointed as CEO of Corsair Pharma</strong>, bringing over 35 years of experience in pharmaceuticals and biotech.</li><li>Corsair’s transdermal patch <strong>promises consistent treprostinil delivery</strong>, potentially overcoming current treatment challenges in PAH.</li><li><strong>Expertise in PAH</strong>: Mahaffey’s experience includes launching Ventavis®, a prostacyclin product, aligning with Corsair’s focus on PAH.</li></ul><p><b>Source: </b><a href="https://www.businesswire.com/news/home/20231211371006/en/Corsair-Pharma-Announces-Appointment-of-George-W.-Mahaffey-as-Chief-Executive-Officer">Business Wire</a></p> </div> </div> </div> </div> </div> </section> <section class="elementor-section elementor-top-section elementor-element elementor-element-e90ba87 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="e90ba87" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0c976b7" data-id="0c976b7" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-5516a40 elementor-widget elementor-widget-heading" data-id="5516a40" data-element_type="widget" data-widget_type="heading.default"> <div class="elementor-widget-container"> <h2 id="notable-quotes" class="elementor-heading-title elementor-size-default">Notable Quotes</h2> </div> </div> </div> </div> </div> </section> <section class="elementor-section elementor-top-section elementor-element elementor-element-d697cb9 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="d697cb9" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0a4aada" data-id="0a4aada" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-91b3c7e elementor-widget elementor-widget-text-editor" data-id="91b3c7e" data-element_type="widget" data-widget_type="text-editor.default"> <div class="elementor-widget-container"> <ul><li>“The potential for transdermal delivery of a treprostinil prodrug may provide physicians and patients with new treatment options that address PAH patients’ need for safety, efficacy, and convenience.” <strong>– George W. Mahaffey, CEO at Corsair Pharma</strong></li><li>“PAH is a devastating disease where there is a clear need for new treatment options offering a meaningful improvement in quality of life for patients suffering with this disease.” <strong>– Ivan Gergel, M.D., Managing Partner at New Rhein Healthcare</strong></li></ul> </div> </div> </div> </div> </div> </section> <section class="elementor-section elementor-top-section elementor-element elementor-element-de5db98 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="de5db98" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-49139f5" data-id="49139f5" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-416ad5a elementor-widget elementor-widget-heading" data-id="416ad5a" data-element_type="widget" data-widget_type="heading.default"> <div class="elementor-widget-container"> <h2 id="sohs-take" class="elementor-heading-title elementor-size-default">SoH's Take</h2> </div> </div> </div> </div> </div> </section> <section class="elementor-section elementor-top-section elementor-element elementor-element-815da73 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="815da73" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-123f65b" data-id="123f65b" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-e1455ae elementor-widget elementor-widget-text-editor" data-id="e1455ae" data-element_type="widget" data-widget_type="text-editor.default"> <div class="elementor-widget-container"> <p>The appointment of George W. Mahaffey as CEO of Corsair Pharma signifies a significant stride in the fight against pulmonary arterial hypertension (PAH). His extensive experience in launching innovative treatments like Ventavis® aligns perfectly with Corsair’s pioneering approach to PAH therapy. The development of their transdermal treprostinil prodrug, aiming to provide a more convenient and effective treatment option, could potentially revolutionize the standard of care for PAH. This aligns with the increasing demand for treatments that not only prolong life but also enhance the quality of life for PAH patients. Corsair Pharma’s innovative approach could be a game-changer in a market projected to grow substantially by 2028, marking an exciting era in PAH treatment.</p> </div> </div> </div> </div> </div> </section> </div> <p><a class="a2a_button_linkedin" href="https://www.addtoany.com/add_to/linkedin?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Fcorsair-pharma-inc-revolutionizes-pah-treatment-with-appointment-of-george-w-mahaffey-as-ceo%2F&linkname=Corsair%20Pharma%20Inc.%20Revolutionizes%20PAH%20Treatment%20with%20Appointment%20of%20George%20W.%20Mahaffey%20as%20CEO" title="LinkedIn" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Fcorsair-pharma-inc-revolutionizes-pah-treatment-with-appointment-of-george-w-mahaffey-as-ceo%2F&linkname=Corsair%20Pharma%20Inc.%20Revolutionizes%20PAH%20Treatment%20with%20Appointment%20of%20George%20W.%20Mahaffey%20as%20CEO" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Fcorsair-pharma-inc-revolutionizes-pah-treatment-with-appointment-of-george-w-mahaffey-as-ceo%2F&linkname=Corsair%20Pharma%20Inc.%20Revolutionizes%20PAH%20Treatment%20with%20Appointment%20of%20George%20W.%20Mahaffey%20as%20CEO" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Fcorsair-pharma-inc-revolutionizes-pah-treatment-with-appointment-of-george-w-mahaffey-as-ceo%2F&linkname=Corsair%20Pharma%20Inc.%20Revolutionizes%20PAH%20Treatment%20with%20Appointment%20of%20George%20W.%20Mahaffey%20as%20CEO" title="Email" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_copy_link" href="https://www.addtoany.com/add_to/copy_link?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Fcorsair-pharma-inc-revolutionizes-pah-treatment-with-appointment-of-george-w-mahaffey-as-ceo%2F&linkname=Corsair%20Pharma%20Inc.%20Revolutionizes%20PAH%20Treatment%20with%20Appointment%20of%20George%20W.%20Mahaffey%20as%20CEO" title="Copy Link" rel="nofollow noopener" target="_blank"></a><a class="a2a_dd addtoany_share_save addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fsliceofhealthcare.com%2Fcorsair-pharma-inc-revolutionizes-pah-treatment-with-appointment-of-george-w-mahaffey-as-ceo%2F&title=Corsair%20Pharma%20Inc.%20Revolutionizes%20PAH%20Treatment%20with%20Appointment%20of%20George%20W.%20Mahaffey%20as%20CEO" data-a2a-url="https://sliceofhealthcare.com/corsair-pharma-inc-revolutionizes-pah-treatment-with-appointment-of-george-w-mahaffey-as-ceo/" data-a2a-title="Corsair Pharma Inc. Revolutionizes PAH Treatment with Appointment of George W. Mahaffey as CEO"></a></p><p>The post <a href="https://sliceofhealthcare.com/corsair-pharma-inc-revolutionizes-pah-treatment-with-appointment-of-george-w-mahaffey-as-ceo/">Corsair Pharma Inc. Revolutionizes PAH Treatment with Appointment of George W. Mahaffey as CEO</a> appeared first on <a href="https://sliceofhealthcare.com">Slice of Healthcare</a>.</p> ]]></content:encoded> <post-id xmlns="com-wordpress:feed-additions:1">13669</post-id> </item> </channel> </rss>